Umoja Biopharma Splash Illustration

  • Umoja In vivo targeted CAR-T immuntherapy

This 3D illustration highlights the key concepts of Umoja Biopharma’s VivoVec and TumorTag technologies for targeted, in vivo CAR-T immunotherapy. Their VivoVec technology enables CAR-T cell generation in the patient, and TumorTags enable precision targeting of those CAR-T cells to tumors. The art reflects Umoja’s brand style so the illustrations can sit seamlessly in the company website and slide decks.

Collaboration with Verge Scientific Communications for Umoja Biopharma.